Clinical practice guidelines for the diagnosis and management of Charcot-Marie-Tooth disease
Charcot-Marie-Tooth disease (CMT) is classified according to neurophysiological and histological findings, the inheritance pattern, and the underlying genetic defect. The objective of these guidelines is to offer recommendations for the diagnosis, prognosis, follow-up, and treatment of this disease...
| Autores: | , , , , , , , , , , |
|---|---|
| Tipo de recurso: | artículo |
| Fecha de publicación: | 2025 |
| País: | España |
| Institución: | Universidad Europea (UEM) |
| Repositorio: | ABACUS. Repositorio de Producción Científica |
| Idioma: | inglés |
| OAI Identifier: | oai:abacus.universidadeuropea.com:11268/16859 |
| Acceso en línea: | https://hdl.handle.net/11268/16859 |
| Access Level: | acceso abierto |
| Palabra clave: | Enfermedad de Charcot-Marie-Tooth Neuropatía Hereditaria Motora y Sensorial España Enfermedad del sistema nervioso Neurología Medicina preventiva Goal 3: Ensure healthy lives and promote well-being for all at all ages |
| Sumario: | Charcot-Marie-Tooth disease (CMT) is classified according to neurophysiological and histological findings, the inheritance pattern, and the underlying genetic defect. The objective of these guidelines is to offer recommendations for the diagnosis, prognosis, follow-up, and treatment of this disease in Spain. These consensus guidelines were developed through collaboration by a multidisciplinary panel encompassing a broad group of experts on the subject, including neurologists, paediatric neurologists, geneticists, physiatrists, and orthopaedic surgeons. |
|---|